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Abstract
Glioblastoma (GBM) is well known to have one of the poorest prognoses among all cancers. Patients with
GBM in progression-free survival (PFS) may be relatively stable and can often maintain their quality of life. Thus,
PFS is a desirable goal. In Japan, the median PFS is 11 months. It is difficult to grasp a patient's thoughts and hopes
when, after PFS, they are readmitted due to recurrence or acute deterioration. Therefore, this study aimed to describe
the lived experience of illness in patients with recurrent GBM, focusing on PFS. We enrolled five patients into the
study; however, only four patients completed data collection. Data were collected using semi-structured interviews.
We also conducted a thematic narrative analysis. As a result, we generated one overall theme: Even in vulnerable
and constrained daily lives, the aim was gaining a sense of stability—and maintaining it steadily—as far as possible,
on their own. That sense of stability is fragile so that maintaining equilibrium is a precarious enterprise. Moreover,
in PFS, participants were trying to maintain equilibrium by reevaluating themselves and sometimes giving up something, although they received support from people around them. We infer that it is important for nurses to assess and
understand the fluctuations in that sense of stability through continuous involvement with patients. An interdisciplinary approach and lateral integration of care are important to meet the needs of GBM patients. This understanding
will lead to nursing supports that help patients live with stability, pride, and dignity.
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Gliomas account for 28.3% of primary brain
tumors. In Japan, gliomas occur at a rate of 6.6 per
100,000 persons (Committee of Brain Tumor Registry of Japan, 2014). According to the World Health
Organization, gliomas Grades III and IV are malignant. Glioblastoma (GBM; Grade IV) is known to
have one of the poorest prognoses among all cancers,
and the median survival rate is 12-15 months (compared with 2-5 years for anaplastic astrocytoma,
Grade III; Pompili, Telera, Villani, & Pace, 2014).
Reports show that of the 1,381 newly diagnosed
GBM patients in Japan, 52.9% already have a severe
neurological deficit (Narita & Shibui, 2015); the onset of disease may be acute or insidious (Cahill &
Armstrong, 2011). Treatment extends the overall survival rate. However, worsening of existing neurological deficits, the appearance of new symptoms and
treatment-associated symptoms may compromise
their quality of life (Cahill & Armstrong, 2011).

Although tumor control or shrinkage by initial
treatment may improve signs, symptoms, and
activities of daily living (ADL; Cahill & Armstrong,
2011; Higuchi, Tanaka, Noguchi, & Kusumi, 2006;
Tsumura, Yamazaki, & Kamibeppu, 2010), tumor
recurrence is frequently unavoidable and incurable
(Tsumura et al., 2010).
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Maintaining a relatively stable quality of life
without progression, regardless of how long it may
last, is important for the patients considering GBM’s
prognosis including the likelihood of additional neurological deficits once recurrence starts. The median
progression-free survival (PFS) period is 11 months
(Committee of Brain Tumor Registry of Japan, 2017).
When these patients are readmitted due to tumor recurrence or if the tumor deteriorates because of neurological deficits, it is crucial to grasp the nature of
their thoughts and hopes because these thoughts and
hopes may guide nurses to provide better care in their
remaining time.
Kleinman (1988) stated that illness is a lived
experience; it can be narrated, and when caregivers
understand its narrative patterns, they can optimally
engage with the patient’s experience. Furthermore,
Kleinman (1988) adds, “Legitimating the patient’s
illness experience—authorizing that experience, auditing it empathically—is a key task in the care of the
chronically ill” (p. 17). That legitimizing of experience requires enlightened listening to the narratives
of patients with GBM throughout the trajectory of
their illness. Therefore, nurses can intervene so that
patients have quality time in PFS.
Patients with high-grade glioma (HGG) are
reported to experience loss of self, a sense of waiting
and uncertainty, and focus on immediate needs in
their illness trajectory (Philip et al., 2014). Other research has reported that HGG patients with neurological dysfunction suffer from the threat of a malignant
brain tumor, confrontation with death, loss of feelings
of self, loss of dignity, and a decline in self-reliance
(Kamma, Sato, & Kuwabara, 2008). Sterckx et al.
(2013) conducted a systematic review, which analyzed 16 qualitative studies of the impact of HGG on
patients and caregivers’ everyday lives. Results found
that at diagnosis, HGG patients felt shocked and recognized death. During different phases of the disease,
patients felt uncertain about the effect HGG would
have on their quality of life and future, and they suffered from the loss of autonomy. In such circumstances, they needed hope, support, and information.
However, these studies included HGG patients in
various phases of the disease trajectory. For example,
Umeda and Iwata (2015) reported that middle-aged
HGG patients in PFS—including three GBM patients—were seeking a way of life that would accommodate this critical, life-threatening experience,
and the crisis of identity it brought. Furthermore,
Iwata (1998) reported on a neurosurgeon and associate professor at a university hospital who suffered
from GBM in his 40s, who recorded what he learned
and felt after he became a patient. He felt fear that he
could expect in detail what would happen to him in
his illness trajectory and realized that there was a gap
between patient’s need and actual medical care. As
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Kleinman (1988) observed, “The trajectory of chronic illness assimilates to a life course, contributing so
intimately to the development of a particular life that
illness becomes inseparable from life history” (p. 8).
Thus, to understand the subjective experiences of
patients with GBM, it is necessary to understand
them in their life context. We found no studies that
described the subjective experience of GBM patients
in PFS and considered the individual voices of patients. Consequently, this study aimed to describe the
lived experience of illness in patients with recurrent
GBM, focusing on the PFS stage of their lives.

Method
In this study, we defined the lived experience of illness as “How patients perceive, live with,
and respond to symptoms and disability” (Kleinman,
1988, p.3). We obtained ethical approval from the
Kyoto University Graduate School and Faculty of
Medicine, Kyoto University Hospital, Ethics Committee (R04730-1).

Design
We used a qualitative narrative study design
to conduct the interviews: “Narrative inquiry enables
participants to tell the story of their experience and
provides an approach to the way people create meaning in their lives by the way they construct their narrative” (Davies, Crowe, & Whitehead, 2016, p, 534).
Narrative inquiry elucidates the participant’s subjective experience.

Participants
Participants who were diagnosed with GBM
recurrence and notified of their disease and its prognosis were recruited at a department of neurosurgery,
in a university hospital in Kyoto, Japan. Their physician, who is a co-author, introduced them to the study.
We included participants if they were aged 20 years
and above, were lucid according to the Japan coma
scale (The Joint Committee on Guidelines for the
Management of Stroke, 2009), and were able to read
and communicate in Japanese (we excluded those
with symptoms of aphasia).

Data Collection
We collected data using semi-structured interviews and through the review of electronic medical
records; we conducted interviews from May to December 2016 to explore participants’ experiences of
living with GBM, including their life stories. The
interviews were focused mainly on perceptions of
their symptoms, current disease status, and prognosis.
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Table 1. Participant Characteristics
Characteristic
Ms. A
Age
In her early thirties
Marital status
Unmarried
Living arrangement
Living
with parents
Work status
Employed
Diagnosis
recurrent GBM

Ms. B
In her late sixties
Unmarried
Living alone

Mr. C
In his early thirties
Unmarried
Living
with parents
Unemployed
recurrent GBM

Retired
recurrent GBM

Ms. D
In her early thirties
Engaged
Living
with parents & fiancé
On sick leave
recurrent secondary
GBM
right frontal lobe

Tumor location

left frontal lobe

right angular gyrus

Time since diagnosis
(months)
PFS* (months)
Off treatment duration
before recurrence
(months)
Treatment history†
(before TMZ monotherapy)

20

15

right supplementary
motor area
112

6
0

18
0

73
20

6
0

surgical resection and
interstitial CT with
carmustine wafers
CRT with TMZ

surgical resection and
interstitial CT with
carmustine wafers
CRT with TMZ

surgical resection
CRT with TMZ

biopsy prior to RT
against diffuse astrocytoma‡
surgical resection of
secondary GBM
7

9

TMZ monotherapy
6
17
47
(courses)
Note. CT = chemotherapy; CRT = chemoradiotherapy; TMZ = temozolomide; RT = radiotherapy
*PFS (Progression-free survival): The length of time during and after the treatment of a disease, such as cancer, that patient lives
with the disease, but it does not worsen (National Cancer Institute, n.d.).
†Treatment history: The standard treatment for newly diagnosed GBM is surgical resection to the extent feasible, followed by
concurrent chemoradiotherapy with TMZ, followed by TMZ monotherapy (Stupp et al., 2005). Furthermore, some new approaches such as carmustine wafers and bevacizumab have been covered by insurance in Japan since 2013. TMZ monotherapy is
required to be a maximum of six courses in Europe and the United States (Stupp et al., 2005), which probably reflects the medical
situation; but in Japan, more than six courses may be covered by the health insurance system depending on adverse events
(Hashimoto, 2016) and patients’ choice.
‡biopsy before RT against diffuse astrocytoma: Ms. D was at the onset of secondary GBM after she received these treatments
about seven years ago.

All participants were interviewed individually after
using the Distress and Impact Thermometer (Akizuki,
Yamawaki, Akechi, Nakano, & Uchitomi, 2005) as a
brief screening tool for adjustment disorders or major
depression in cancer patients. We conducted interviews for about one hour at a time. Furthermore, the
investigator interviewed participants several times
(whenever possible, deferring to the participant’s
condition) when, during data analysis, the need arose
for additional questions or analysis suggested a result
that might differ from what subjects had reported.

Data Analysis
A thematic narrative analysis (Riessman,
2008) was performed to describe the individual experiences of illness in detail. It was challenging to recruit subjects because GBM is rare and symptoms
vary widely depending on the location of the tumor.
Thus, we anticipated that the experience of each patient would be unique. A thematic narrative analysis
was focused on the content of speech exclusively and
works from a case-centered model that enables to the
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researcher to “keep a story ‘intact’ by theorizing from
the case rather than component themes (categories)
across cases” (Riessman, 2008, p. 53).
We used the thematic-narrative analysis procedure to analyze the data (Braun & Clarke, 2006;
Riessman, 1993, 2008). The interviewer transcribed
interviews verbatim. Three investigators read the
transcripts. Next, we analyzed each case ordering
episodes into a chronological, biographical account,
coding and identifying sub-themes and themes. In
this analysis, we specifically focused on the experience of the period of PFS, from the end of the initial
treatment to the recurrence. We then linked the
themes among the four participant transcripts for a
global analysis. We checked all themes presented in
the data and individual analysis against each other
and checked against the original data. Finally, we
identified common themes and an overall main theme.

Reflexivity and Rigor
To ensure objectivity, we analyzed the interview data independently and then discussed the data
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with three investigators: a principal investigator and
two collaborative researchers, both of whom had experience in qualitative research including narrative
studies. Finally, we carefully triangulated the analyzed data with an expert researcher in palliative care
nursing and qualitative research methods. Furthermore, to ensure the internal validity of the data interpretation, the participants confirmed the results as
much as possible (Sakurai & Kobayashi, 2005).

Results
Patient Characteristics
The participants were originally five adult
patients with recurrent GBM, two males and three
females, who had varying levels of physical function
but were all-lucid. Five patients consented to participate; the authors due to clinical deterioration, leaving
four subjects to complete the study, withdrew one
subject. The average age of the four participants was
41.5 years (SD ± 17.8); the mean PFS was 28.7
months (SD ± 32.0). Table 1 shows the participant
characteristics.

Patient Experience
We analyzed the four chronological biological accounts and identified themes in the experience
of PFS per participant. We found four sub-themes
from Ms. A, three sub-themes from Ms. B, two subthemes from Mr. C, and seven sub-themes from Ms.
D. These themes, including the raw data, were compared and linked in a global analysis. As a result,
three common themes emerged:
• Living vulnerable daily lives with uncertainty about the future and physical symptoms.
• Gaining a sense of normality and attempting
to maintain it.
• Coping with bouts of pain while maintaining
that sense of normality in daily life.
From these three themes, we distilled an overall main
theme of the lived experience of GBM patients who
had experienced PFS: Even in vulnerable and constrained daily lives, the aim was gaining a sense of
stability—and maintaining it steadily—as far as possible, on their own. In the following sections, the
details of those three common themes are described
by referring to the raw data—translations from the
participants’ own words.

Living vulnerable daily lives with uncertainty about the future and physical symptoms
Participants knew the characteristics of
GBM, including the fact of inevitable recurrence and
prognosis. Furthermore, that knowledge made them
aware of their limited life expectancy and uncertain
future:
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•

“I heard from my sister about the life expectancy being two or three years. If it recurs, I
do not know whether or not adequate treatment is available, but I did hear that it will
be sure to relapse, so I will cross that bridge
when I come to it” —Ms. B.
Moreover, participants had uncertainty about
physical symptoms. They were always aware of the
risks of sudden physical deterioration, such as a seizure caused by GBM, and they maintained epilepsy
precautions. Furthermore, the uncertainty led to mental pain:
• “I am not sure what will happen, I’m scared
a bit…”—Ms. A.
• “I heard [that I will] never know when I collapse”—Ms. B.
• “[Regarding preventive behavior] I think I
should do it because I cannot do many
things if I collapse. It’s important after
all”—Ms. D.
Under such circumstances, when the participants
thought about their uncertain future, recurrence, and
prognosis, they tried to be positive and focused on
the immediate situation:
• “I try to live every day with a smile as much
as possible because my friends advised me
that depression can accelerate the disease
progression” —Ms. B.
• “I need positive thinking to get me through
[this] illness. I try to think positively rather
than negatively because I become more and
more negative when I think negatively”—
Ms. D.
Each participant spent a stable everyday life
in PFS although they realized that their disease would
persist. Ms. A’s daily life was almost the same as her
premorbid life, without subjective symptoms. Ms. B
was proud that she had overcome another life crisis,
precipitated by acute hydrocephalus, before GBM.
She reported a life wherein she perceived GBM as a
serious disease but also valued her own current good
physical condition. Mr. C spent a life without subjective symptoms after reoperation. Finally, Ms. D believed she was gradually getting better and had a plan
to return to work. Overall, during the PFS stage,
these participants hoped that their condition would
stabilize, and they were able to think a little optimistically:
• “[I think,] just vaguely, well, I guess I might
die, but... I was hospitalized because I was
about to die. Hmm..., I overcame that, so I
wonder if it will work out in the future” —
Ms. B.
• “After the second surgery, actually, my
symptoms were getting better. I was okay after that, at that time”—Mr. C.
• “I thought it would last—a good condition
like this” — Ms. D.
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In this way, they mentally distanced themselves from
the dire prognosis that they had heard during hospitalization.
The participants experienced recurrence. All
of them recognized that they would relapse someday,
but Mr. C and Ms. D, who had exacerbated symptoms, felt the effect of relapse more acutely. Ms. A
and Ms. B did not notice symptoms, as they stated
the following in a bland tone:
• "I do not know [my condition] because I had
no symptoms, but I realized it when I was
shown my MRI image”—Ms. A.
• “Although I relapsed…” —Ms. B.
Mr. C and Ms. D both expressed their surprise at relapse. Although Mr. C (the longest survivor) knew recurrence was frequently unavoidable, he
was surprised by not only the recurrence but also
motor dysfunction because he had spent about six
years without any dysfunction or relapse. Meanwhile,
Ms. D (shortest survivor) thought there was still a
considerable amount of time before relapse:
• “Finally! It actually happened; I felt the time
has come, but I never thought I would need
a stick when I walk”—Mr. C.
• “I began to collapse, but I never expected
the recurrence; I thought that relapse was
still a little way off”—Ms. D.
These participants believed that they were
getting better and regained their positive attitudes
toward PFS. However, no one knew when the brain
tumor would recur; its stability was always at risk, so
they felt vulnerable in their daily lives. Even if the
patients’ condition is, good and regardless of whether
the disease duration is long or short, their vulnerability remains as long as they have GBM. However,
despite the vulnerability, they focused on the stable
factors in their immediate situation rather than focusing on the thoughts of an uncertain future.

Gaining a sense of normality and attempting
to maintain it
During PFS, participants did not have physical pain from symptoms, but they did experience side
effects such as nausea, anorexia, and constipation
within five days of chemotherapy (temozolomide
monotherapy for five days every four weeks). Participants took constant precautions against epileptic
seizures:
• “Actually, I had nausea during taking temozolomide. Because I never knew when I
vomited, I was always in the kitchen whenever I vomited” —Mr. C.
In their PFS situation, they adapted their daily lives (e.g., meals, means of transportation) to accommodate their post-diagnosis situation. As the participants met the needs that changed from their
premorbid life, they reported little trouble; participants complimented those around them for assisting.
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Thereby, the participants obtained the subjective feeling that they were spending normal lives.
Ms. A did not experience any physical distress after being discharged from surgery. She returned to work on the fifth day after discharge. She
has become able to work as well as she did before the
occurrence of disease, receiving assistance from others in her surroundings:
• “I returned to work from the beginning of
the week after discharge; I was fine. I cannot
drive a car now, so my parents ride to work.
I told my boss about my disease”—Ms. A.
Although Ms. B experienced a life crisis at
the onset of GBM, the symptoms disappeared when
she was discharged. Therefore, she could resume
retirement life as she had lived before the occurrence
of disease by substituting other means such as using
personal deliveries for daily shopping and a microwave without gas:
• “I got well very much by rehabilitation after
surgery, so I became rather normal. As rehab
allowed my legs to move relatively quickly,
and I could stand on one foot, actually I had
not been having so much in trouble with daily life”—Ms. B.
Although Mr. C had intermittent numbness
in left his leg, he could do carpentry as he did before
diagnosis. That work convinced him he was no different from a healthy person:
• “The lumber was big, but I was strong
enough for it. I did not feel that my physical
strength had declined.” —Mr. C.
Thus, three of the participants were able to
realize normal functioning relatively early in PFS by
keeping the ADL almost the same as before diagnosis.
Ms. D thought she was no longer normal because
surgery had lessened the fine motor function in her
left hand. However, she felt she should be normal,
and she pursued that goal by setting normal standards
on her own. Because she went through a smooth recovery process supported by her loved ones, she was
able to feel that she was normal:
• “Although I think perhaps healthy persons
who are not sick also have a day like they
feel down, feel a bit badly today, and feel
like spoiling myself. I think the normal is
maybe that I can manage those kinds of
things well by a change of pace, increasing
motivation. So, I was like I evaluated myself
by just wondering how much the days like
that would increase”—Ms. D.

Coping with bouts of pain while maintaining
that sense of normality in daily life
All of the participants lived in PFS with independent ADL, without symptoms that reminded
them of their GBM. Thus, during PFS, the participants felt themselves to be normal despite their GBM
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diagnosis. Still, at times, the participants suffered
intractable pain. In particular, by leading a daily life
that felt normal, they could feel they met even higher
needs such as a self-actualization. The participants
were aware of social pain. Saunders (1989) described
the concept of pain by using the term "total pain," the
sum of the physical, psychological, social, spiritual,
and emotional elements that construct the total pain
experience. Social pain refers to suffering to function
every day, such as balancing the stressful situations
of living with cancer, economic problems, work and
resocialization, relationships with family, and care
burdens (Japan Nursing Association, 2014). Participants suffered from increased living expenses including medical expenses, a sense of guilt for burdening
their families, and limitations on their hobbies and
entertainment.
Ms. A had no choice but to rely on her parents for driving a car; she was sorry for her parents.
She felt disgusted about her narrow range of activities. Furthermore, she was also concerned about persistent hair loss from radiotherapy, and her body image was changing— a major problem especially for a
woman in her 30s:
• “I’d like to drive extremely, as I can’t … No,
not pain; actually, hair the loss was terrible
— the most terrible thing. Around here, if
you look closely, there is still no hair” —Ms.
A.
Ms. B looked back at her life and mused
about the reason for getting GBM:
• “I sometimes wonder if getting GBM is the
punishment for many years of having [an]
affair” —Ms. B.
At the same time, she said it brought up the most
important memories of her life. Furthermore, when
considering her death vaguely, she expressed spiritual
pain. She had hoped to live longer, and she had a hard
time motivating herself to sort through her belongings for her sisters.
• “I sometimes wonder if I deserved it. Well,
actually, I just wonder if it cannot be helped,
and I cannot be cured because I am old
enough and living alone. But I just think that
I have to settle for things until death”—Ms.
B.
Mr. C reported no change regarding how to
live, including his way of working. However, he did
report economic distress from continuing the expensive chemotherapy. He was suffering from unstable
symptoms that appeared when he got tired. Although
sometimes he had regrettable experiences while
working, economic pressure forced him to work. He
was a young, independent ADL, and ostensibly able
to work normally. He was suffering from social pain
because it was difficult for him to find good employers and to access social welfare systems other than
high-cost medical expense benefit. Mr. C reported
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why he had no choice but to quit chemotherapy in the
fifth year:
• “I was no longer able to keep taking the
medicine due to economic difficulty…but, I
guess I have not been able to continue medicine [temozolomide] without receiving welfare like now. I am thinking that it cannot be
helped though. Well, actually, my economic
situation was so bad” —Mr. C.
Ms. D felt that she was recovering smoothly
and was able to think positively. However, as for her
dysfunctional left hand, she wanted to return to normal—her health status before her diagnosis. She had
concerns:
• “Even though I know in my head that it [a
complete cure] is impossible, I have gotten
better. So, I cannot stop thinking, I wish I
could return to my old self as premorbid.”
—Ms. D.
Furthermore, she was sorry to put a burden on her
parents, and she worried about the future with her
fiancé:
• “I live in my parents’ house. Well, I cannot
afford an apartment fee; I feel like I cannot
survive unless I live with my parents. I am
sorry for my parents, though”—Ms. D.

Discussion
This study has cast a spotlight on how GBM
patients perceive their life and how they cope with
their illness. It was important for them to acquire and
maintain a sense of normality on their own for adaptation in PFS. The results of this study present critical
insights for nursing, as nurses seek to give patients
quality time in PFS, by supporting their sense of
normality with an interdisciplinary approach and lateral integration of care. We identified patients’ narratives that may assist nurses to support patients, families, and clinicians for decision-making to prepare for
the death to come.

The Meaning of Their Uncertainty
Patients perceived that the uncertainty due to
an illness restricted their daily lives. Their uncertainty
was caused by an unclear future, unpredictable medical condition and treatment effect, and unfamiliar
illness, GBM itself. Our results support Mishel’s explanation, “Uncertainty is generated by events characterized as vague, ambiguous, unpredictable, unfamiliar, in-consistent, or lacking information” (Mishel,
1984, p. 163). The prognosis of GBM forces patients
to face the limitation of life left, which perpetuates
uncertainty. However, participants were looking
back on their life, considering what was now important for them in the light of continual uncertainty.
Thus, the participants were aware of thinking posi-
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tively, focusing on their immediate lives, and setting
their goals. Our results support Mishel’s explanation
that “the new view of uncertainty as a natural phenomenon is a new view of the world in which instability and fluctuation are natural and increase the
person’s range of possibilities” (Mishel, 1990, p. 261).
Eventually, they may have approached adaptation to
their changed lives, which are proposed as the end
state achieved after coping with uncertainty (Mishel,
1990). The present results suggest that uncertainty,
though fluctuating, is becoming weaker compared
with what the participants felt at diagnosis. Although
they kept relapse and death “in the back of their
head,” those images faded somewhat.

The Meaning of the Sense of Normal:
Equilibrium
Participants in the present study had few or
no physical symptoms except during chemotherapy.
They experienced normalcy in their daily lives. The
participants adjusted to their lives with GBM by delegating tasks to loved ones to make their everyday
lives appear normal.
Johnson (1961) explained, “Equilibrium derives primarily from this stability-constancy concept.
Equilibrium is viewed rather as a stabilized, but more
or less transitory, resting state in which the individual
is in harmony within himself and with his environment” (p. 65). Also, equilibrium takes place at points
that the patient feels optimal gratification and minimal deprivation of his need-dispositions. We suggest
that these patients felt the subjective sense of normalcy, that is, a sense of stability on their own through
the re-establishment or maintenance of their equilibrium. However, it’s likely that the equilibrium of
GBM patients is fragile; their sense of stability included vulnerability.

The Meaning of the Social Pain
The participants often suffered social pain,
although they had been performing ADLs independently, without GBM symptoms, while they
gained a sense of stability during their PFS. Participants had social pain in common, such as the burden
placed on families, the difficulty in returning to and
continuing work, limitations on former hobbies and
entertainment, concern about their future, and living
expenses including medical expenses.
Notably, the three participants in their 30s
(Ms. A, Mr. C, and Ms. D), had stronger social pain.
Based on Erikson’s (1980) psychosocial theory of
development, they were at the stage between young
and middle adult. During these stages, significant
relationships with marital partners and friends and
working are important. No matter how they had been
obtaining and maintaining a sense of stability on their
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own, it was often hard for them to accomplish the
developmental challenges of their stage due to GBM.
Therefore, they were sometimes frustrated because
they were strongly aware of the restrictions on their
daily lives.
In comparison to the younger participants,
Ms. B (in her late 60’s) had more frequent remarks
about spiritual pain, such as thinking about the meaning of illness and reflecting on her life. According to
Erikson’s (1980) theory, Ms. B was at the development stage of late adulthood, which involves accepting that one’s life is one’s responsibility through
much reflection. Her spiritual pain was particularly
related to the Erikson’s development challenge of this
stage.

Implication for Nursing
Any sense of stability among patients is
likely to collapse because of living with an unpredictable disease like GBM. There is a delicate balance involved in maintaining a stable state of equilibrium, which can easily fluctuate and result in a feeling of vulnerability. Moreover, in PFS, subjects were
trying to maintain equilibrium by themselves, sometimes by giving up something, although they received
support from their loved ones.
As a premise, nurses are required to understand that patients are not necessarily optimistic just
because they feel a sense of stability; they may also
feel vulnerable at the same time. Also, through continuous involvement with patients, skilled nurses will
grasp how each sense of stability fluctuates, and the
nurses will provide support-oriented solutions, such
as concrete and adequate information, that supports
hope as much as possible. If at some point the patient
is unable to feel hope, it would be helpful if we could
connect the patient with a non-profit volunteer organization. However, currently in Japan, although there
are organizations for children with intractable diseases
such
as
Make
a
Wish®
Japan
(http://www.mawj.org/en/), for adults, there is only
the cancer salon aimed at peer-support for survivors.
Social welfare support has little available if patients
have no or mild disability. Even if the condition is
stable and the patient can perform ADL independently, hope may dwindle; thus, it is urgent that we develop support systems in light of the disease’s severe
prognosis. Otherwise, regardless of what the patient
chooses, it is necessary to support their choice and
encourage their confidence in it. These interventions
will lead to developing a good relationship and symptom management and help patients prepare for the
day to come, maximize inner stability, and optimize
the choices they still have. Therefore, it is important
for nurses to communicate effectively and integrate
care laterally, including the hospital, outpatient settings, hospice, and rehabilitation settings. In fact, the
Japanese government is promoting “community-
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based integrated care systems,” to facilitate collaboration among various occupations and organizations.
These systems are planned for completion by 2025
when Japan’s aging population is estimated to reach
about 30% (Naruki, 2016). The system is still developing, and for these GBM patients in PFS, it is critical to promote the lateral integration of care as soon
as possible.

Limitations
In this study, we interviewed patients after
the recurrence of GBM. Although there is a possibility that their memories of what they narrated are not
accurate, narrative inquiry is focused on the life history of patients to understand their subjective experience. Therefore, personal narrative is interpreted by
the narrator at that time, is characterized by values
and motivation, and is a subjective reality. As long as
the narrative inquiry aims to understand subjective
reality, internal validity is required rather than exploring the only true story (Sakurai & Kobayashi, 2005).
As we received suggestions during the analysis, we
conducted as many additional interviews as possible
to confirm the internal validity, depending on the
condition of the patients. It was difficult to conduct
additional interviews because of the physical and
mental deterioration of the patients in several cases.
GBM is a progressive disease, and the speed of progression after recurrence is often much faster than
before its recurrence. Therefore, it cannot be said that
we were able to collect all narratives. Furthermore,
there were varying locations and symptoms of the
tumor, duration of disease, and other factors in our
participants. The tumor size and tumor location are
significant because these affect the prognosis and
various clinical symptoms. Because the tumor location in our participants allowed maximum safe surgical resection, it may have been less disabling. Meanwhile, there are many patients with some disability in
PFS. Further analysis is needed to consider the differences in tumor location and symptoms, disease
duration, genotype, and other factors.

Conclusions
Overall, the theme of the lived experience of
illness in GBM patients focused on PFS can be expressed, even in vulnerable and constrained daily
lives, the aim was gaining a sense of stability—and
maintaining it steadily—as far as possible, on their
own. Patients with GBM perceived restriction and
vulnerability in daily life owing to chronic uncertainty. Because of responding to this uncertainty, participants were able to adapt to how their lives had
changed from pre-illness and to attain a sense of stability on their own. They then attempted to maintain a
certain, stable feeling of living in the present moment.
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Nurses are required to understand and respect patients’ situations. We suggest that in PFS, it is
important for nurses to continue to engage with outpatients, develop a good relationship through conversations and symptom management, and help patients
to prepare themselves for the end-of-life phase so that
they can live as they wish and maintain an inner
sense of stability. Thus, it is important for nurses to
use effective communication in an interdisciplinary
approach and lateral integration of care to meet the
needs of GBM patients in PFS. However, further research is needed, which includes larger ongoing cohorts, to explore specific nursing interventions.
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